Evidence map›Paper›PMID 42503643›Full record

ArticleBrain pathology (Zurich, Switzerland)2026

The immunological landscape of the area postrema in neuromyelitis optica spectrum disorders.

Qian Yu, Yoshiki Takai, Naoya Yamazaki, Sarah Brandl, Katharina M Mair, Thibault Bouderlique, Maria Eleni Kastriti, Igor Adameyko, Romana Höftberger, Markus Reindl and 2 more

Abstract read
In one paragraph

Article in Brain pathology (Zurich, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Qian YuCenter for Brain Research, Division of Neuroimmunology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0009-0003-7585-1037
Yoshiki TakaiDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Naoya YamazakiDepartment of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Sarah BrandlClinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.ORCID https://orcid.org/0009-0000-8300-5875
Katharina M MairCenter for Brain Research, Division of Neuroimmunology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0003-3339-0714
Thibault BouderliqueCenter for Brain Research, Division of Neuroimmunology, Medical University of Vienna, Vienna, Austria.
Maria Eleni KastritiCenter for Brain Research, Division of Neuroimmunology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-0563-7399
Igor AdameykoCenter for Brain Research, Division of Neuroimmunology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0001-5471-0356
Romana HöftbergerDivision of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-5769-1100
Markus ReindlClinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.ORCID https://orcid.org/0000-0003-2817-1402
Jan BauerCenter for Brain Research, Division of Neuroimmunology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0001-5802-8047
Monika BradlCenter for Brain Research, Division of Neuroimmunology, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0003-2239-1586

Funding

Austrian Research Promotion Agency FO999920011Austrian Science Fund 10.55776/EFP9Austrian Science Fund 10.55776/PAT6054424Austrian Science Fund I6565-B SYNABSIIAustrian Science Fund PIN9333824China Scholarship Council CSC202306170046Intramural Funding Program of the Medical University Innsbruck PhD Research Training Groups 2022-1-2 CONNECT
6 · The paper itself

Abstract

Patients suffering from aquaporin-4 antibody-positive neuromyelitis spectrum disorder may present with radically different types of lesions in the central nervous system. They may show large tissue destructive lesions, as typically seen in medulla, spinal cord, and optic nerves, and lesions with much better tissue preservation, as seen in the area postrema. The causes for the resilience of the area postrema to the action of aquaporin 4-antibodies are currently unclear. We performed detailed immunohistochemical analysis combined with spatial transcriptomics and functional annotation clustering, and identified key differences in the immunological landscape between the area postrema and the medulla. In the area postrema, only few chemokines were upregulated in response to AQP4 antibodies. Therefore, the immune response was dominated by local microglial/macrophages which displayed a low grade of microgliosis and an overall low level of activation. Il-1β expression was below our cut-off for detection. This was in marked contrast to lesions in the medulla, which were characterized by the expression of many chemokines underlying the recruitment of macrophages and neutrophils from the periphery to this site, and by Il-1β expression. Aldehyde dehydrogenase 1 family member A2 (Aldh1a2), the key molecule for retinoic acid synthesis, was strongly expressed in the area postrema, but not in the medulla. Because retinoic acid can prevent the activation of astrocytes and microglia, can reduce the production of cytokine/chemokine transcripts, can alleviate the expression of IL-1β, and can promote an M1- to M2-transition in macrophages, our data implicate a protective role of retinoic acid at this site.

Indexed as

animal modelarea postremachemokinesmicroglianeuromyelitis opticaretinoic acid

Identifiers

PMID42503643
PMCPMC13402650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.